Autism Biomarkers Consortium for Clinical Trials

What is this study about?

What is this study about?  The aim of the consortium is to develop reliable and objective measurements of social function and communication in people with autism. Using EEG to measure brain function, eye tracking technology to measure visual attention, and automated recording techniques to assess behavior and speech, children will be monitored over a six-month period. In addition to the behavioral measures and biomarker data, this community resource will also include DNA samples from children with ASD and their parents for use in future genetic studies. The goal is to create a set of measures that can be used in clinical trials to determine which treatments are best for which patients and who will benefit from a particular treatment. The ultimate goal is to validate a set of tools that will enable clinicians to objectively measure and predict how children with ASD respond to treatment.​

How much time does it take?

Caregivers will complete a screening phone call and questionnaires about their child. Children will complete in-person study visits at Boston Children’s Hospital over a 6 month period. Scheduling is flexible including weekends. ​      

Who can be in the study? 

We are currently recruiting both typically developing children and children with a diagnosis of ASD. 

Who do I contact if I'm interested in hearing more about the study? 

To learn more about the study or to participate, please call us at 857-218-3182 or email our team at